You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 4, 2024

CLINICAL TRIALS PROFILE FOR TESTOSTERONE UNDECANOATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Testosterone Undecanoate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00117000 ↗ The Effects of Testosterone and Nutritional Supplementation in the Undernourished Elderly Unknown status Organon Phase 3 2003-07-01 The purpose of this study is to determine what effect treatment for one year with testosterone and a nutritional supplement, alone and combined, has on the adverse effects of under-nutrition in community-dwelling older men and women.
NCT00117000 ↗ The Effects of Testosterone and Nutritional Supplementation in the Undernourished Elderly Unknown status University of Adelaide Phase 3 2003-07-01 The purpose of this study is to determine what effect treatment for one year with testosterone and a nutritional supplement, alone and combined, has on the adverse effects of under-nutrition in community-dwelling older men and women.
NCT00119483 ↗ Older Men and Testosterone Completed University Hospital of North Norway N/A 2005-09-01 Male hypogonadism is a clinical situation characterized by a low serum testosterone level in combination with a diversity of symptoms and signs such as reduced libido and vitality, decreased muscle mass, increased fat mass and depression. Similar symptoms in combination with subnormal testosterone levels are seen in some elderly men. Low testosterone levels are associated with known cardiovascular risk factors, and men with diabetes and stroke have lower testosterone levels than healthy men. Even though several publications have suggested that testosterone treatment in hypogonadal men may have beneficial effects, it is still uncertain if testosterone substitution in the aging man is indicated. Despite this uncertainty the sale of testosterone has increased enormously the last few years. We hypothesize that older men with subnormal testosterone levels have a varying degree of dysfunction/symptoms both physically and mentally, and that these dysfunction/symptoms can be improved with testosterone treatment.
NCT00146146 ↗ Testosterone and Its Metabolites in GID Completed Schering-Plough Phase 3 2005-05-01 The purposes of this study are: - to determine the role of testosterone versus dihydrotestosterone with respect to the following physiological functions: bone metabolism, body composition, insulin resistance and lipid profile - to determine the role of testosterone and dihydrotestosterone versus estradiol with respect to the following physiological functions: bone metabolism, body composition, insulin resistance and lipid profile
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Testosterone Undecanoate

Condition Name

Condition Name for Testosterone Undecanoate
Intervention Trials
Hypogonadism 19
Hypogonadism, Male 10
Male Hypogonadism 8
Testosterone Deficiency 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Testosterone Undecanoate
Intervention Trials
Hypogonadism 37
Eunuchism 13
Diabetes Mellitus, Type 2 3
Sarcopenia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Testosterone Undecanoate

Trials by Country

Trials by Country for Testosterone Undecanoate
Location Trials
United States 100
Germany 12
Thailand 3
United Kingdom 3
Mexico 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Testosterone Undecanoate
Location Trials
California 12
Florida 9
Alabama 8
Texas 7
New York 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Testosterone Undecanoate

Clinical Trial Phase

Clinical Trial Phase for Testosterone Undecanoate
Clinical Trial Phase Trials
Phase 4 9
Phase 3 18
Phase 2/Phase 3 4
[disabled in preview] 16
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Testosterone Undecanoate
Clinical Trial Phase Trials
Completed 43
Not yet recruiting 5
Unknown status 5
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Testosterone Undecanoate

Sponsor Name

Sponsor Name for Testosterone Undecanoate
Sponsor Trials
Clarus Therapeutics, Inc. 11
Bayer 5
Syneos Health 4
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Testosterone Undecanoate
Sponsor Trials
Other 76
Industry 41
NIH 4
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.